EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neoplastic risk in hyperplastic esophagogastric junction lesions: Comprehensive multicenter study

Elena De Cristofaro iD, Federico Barbaro, Jérôme Rivory, Alexandru Lupu, Benedetto Neri iD, Dario Biasutto, Gianluca Andrisani, Rui Morais iD, Franscisco Mendes, João Santos-Antunes iD, Germana de Nucci iD, Sandro Sferrazza und 21 weitere

Endoscopy International Open · 16.12.2025 · 13 (CP)

DOI: 10.1055/a-2760-6753 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 16.12.2025. Verfasst von Elena De Cristofaro und 32 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Surgery, Gastroenterology, University of Rome Tor Vergata, Rome, Italy. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophagogastric junction (EGJ) lesions are uncommon and histologically diverse. Among these, EGJ hyperplastic lesions are rare and generally considered benign. However, their nonspecific appearance makes accurate endoscopic identification challenging. Endoscopic resection is both a diagnostic and therapeutic approach, yet risk factors for neoplastic transformation in EGJ lesions remain unclear. This study aimed to identify predictive factors for neoplastic transformation in hyperplastic EGJ lesions. This multicenter, retrospective study included patients with hyperplastic EGJ lesions endoscopically resected across 13 European hospitals. Data were collected from endoscopy and pathology reports. Neoplastic transformation was defined by presence of dysplasia or adenocarcinoma. A multivariable logistic regression model was conducted to assess predictive factors for neoplastic transformation in resected hyperplastic lesions. From January 2015 to October 2024, 91 EGJ hyperplastic lesions were included. Polypectomy/endoscopic mucosal resection (EMR) was performed in 86% of cases, endoscopic submucosal dissection (ESD) in 19%. En bloc resection was successfully achieved in 93% of cases, whereas R0 resection rates were confirmed in 84% of cases. Twenty-one lesions (23%) showed neoplastic transformation on histology. Independent predictive factors for neoplastic transformation in hyperplastic lesions included non-polypoid morphology (odds ratio [OR] 5.48; P = 0.025), presence of surface ulceration (OR 11.5; P = 0.0005) and lesion size (OR 5.48; P = 0.021). Lesion size > 12 mm was identified as a significant predictor of neoplastic transformation in hyperplastic lesions. EGJ hyperplastic lesions showed a non-negligible risk of neoplastic transformation. These findings highlight the need for careful endoscopic assessment to predict malignancy while promoting appropriate management strategies to ensure adequate R0 resection in case of undetected local malignancy.

Schlagwörter

Stichwörter der Autor:innen

Diagnosis and imaging (inc chromoendoscopy, NBI, iSCAN, FICE, CLE)Endoscopic resection (ESD, EMRc, ...)Endoscopy Upper GI TractPrecancerous conditions & cancerous lesions (displasia and cancer) stomach

Autor:innen und Institutionen

  • Faculty of Medicine and Surgery, Gastroenterology, University of Rome Tor Vergata, Rome, Italy.
  • Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
  • Gastroenterology, Edouard Herriot Hospital, Lyon, France.
  • Gastroenterology and Endoscopy, Pavillon L Edouard Herriot Hospital, Lyon, France.
  • Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy.
  • Therapeutic GI Endoscopy Unit, Campus Bio-Medico University Hospital, Roma, Italy.

ORCID-Profile: Elena De Cristofaro, Benedetto Neri, Rui Morais, João Santos-Antunes, Germana de Nucci, Lucile Héroin, Giulio Antonelli, Simona Agazzi

Zitieren

APA

De Cristofaro, E., Barbaro, F., Rivory, J., Lupu, A., Neri, B., Biasutto, D., Andrisani, G., Morais, R., Mendes, F., Santos-Antunes, J., de Nucci, G., Sferrazza, S., Pecere, S., Dahel, Y., Ratone, J. P., Rovedatti, L., Spada, C., Di Matteo, F. M., Anderloni, A., …, & Pioche, M. (2025). Neoplastic risk in hyperplastic esophagogastric junction lesions: Comprehensive multicenter study. Endoscopy International Open, 13(CP). https://doi.org/10.1055/a-2760-6753

Vancouver

De Cristofaro E, Barbaro F, Rivory J, Lupu A, Neri B, Biasutto D, et al. Neoplastic risk in hyperplastic esophagogastric junction lesions: Comprehensive multicenter study. Endoscopy International Open. 2025;13(CP). doi:10.1055/a-2760-6753

BibTeX
@article{DeCristofaro2025,
  author = {De Cristofaro, Elena and Barbaro, Federico and Rivory, Jérôme and Lupu, Alexandru and Neri, Benedetto and Biasutto, Dario and Andrisani, Gianluca and Morais, Rui and Mendes, Franscisco and Santos-Antunes, João and de Nucci, Germana and Sferrazza, Sandro and Pecere, Silvia and Dahel, Yanis and Ratone, Jean-Philippe and Rovedatti, Laura and Spada, Cristiano and Di Matteo, Francesco Maria and Anderloni, Andrea and Leclercq, Philippe and Romeo, Samanta and Manfredi, Guido and Stasi, Elisa and Jacques, Jeremie and Troncone, Edoardo and Héroin, Lucile and Maitre, Jerome and Berger, Arthur and Antonelli, Giulio and Agazzi, Simona and Del Vecchio Blanco, Giovanna and Monteleone, Giovanni and Pioche, Mathieu},
  title = {Neoplastic risk in hyperplastic esophagogastric junction lesions: Comprehensive multicenter study},
  journal = {Endoscopy International Open},
  year = {2025},
  volume = {13},
  number = {CP},
  doi = {10.1055/a-2760-6753}
}
Kostenlos starten →